Jefferies Financial Group’s Amicus Therapeutics FOLD Stock Holding History

Jefferies Financial Group’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-143,700	Closed	-$2.04M	–	1741
2023 Q4	$2.04M	Sell	143,700 -30,900	-18%	-$351K	0.01%	704
2023 Q3	$2.12M	Buy	174,600 +108,900	+166%	+$1.4M	0.02%	607
2023 Q2	$825K	Buy	+65,700	New	+$780K	0.01%	997

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Jefferies Financial Group's FOLD Position: Q2 2026 in Review

Jefferies Financial Group sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 40,300 shares — an estimated $583K sold.

Jefferies Financial Group first reported a position in FOLD in Q2 2023 and held it in 8 quarters. The position peaked at $2.36M in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Jefferies Financial Group reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Jefferies Financial Group sold 40,300 Amicus Therapeutics shares in Q2 2026, an estimated $583K.
Jefferies Financial Group first reported a position in Amicus Therapeutics in Q2 2023 and held it in 8 quarters.
Jefferies Financial Group's Amicus Therapeutics position peaked at $2.36M in Q4 2025.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.